There’s still a lot of unpacking to do with this Nate Marquardt story. While Marquardt broke his silence and detailed his use of testosterone replacement therapy, there now appears to be an issue with New Jersey that needs sorting out. The future of his fighting career – he was fired by the UFC and is currently serving an indefinite suspension in Pennsylvania — hangs in a precarious balance.
There’s also a list of people directly and indirectly connected to this story. One of those people is Marquardt’s trainer, Trevor Wittman, who objects to the use of TRT in response to natural drops in testosterone production.
“To me, if your testosterone levels are getting lower over the years, that’s normal. You’re getting older,” Wittman told MMA Fighting’s Ben Fowlkes. “If you have a 21-year-old come into this with those naturally high testosterone levels, and then you’ve got an older fighter — I’ll just pick an age, say, 35 — who has lower testosterone levels, the advantages of the older man are knowledge, experience.
“But if we make a 35 or 40-year-old fighter as strong as a 21-year-old, to me, that’s cutting corners.”
While Wittman believes Marquardt has been honest with him, that he really believed he needed TRT treatment, Wittman feels he needs to be more proactive with his fighters going forward.
“I look at it as white and black, like you’re still doing an enhancing kind of thing,” Wittman said. “But if the doctor okays it, does that make it right? I don’t know. That’s something I can’t explain, but I’ll tell you what I’m doing now, and that’s sit down with every fighter I deal with and find out if they’re seeing a doctor and for what reason. If it’s anything that has to do with enhancing, then I’m going to step away.”
These are big words from Wittman, who obviously has his gym’s reputation to maintain. That gym is now dealing with its second steroid-related scandal within the twelve months. In August of last year, Shane Carwin was named in a federal investigation for allegedly receiving shipments of various steroids from Applied Pharmacy Services in 2006..
About the author